Although epidemiological associations between XP-C, -D, and -F polymorphisms and increased melanoma risk have been reported [7], [8], [9], [10], no firm evidence to our knowledge supports a major role for NER pathway gene mutations in either familial or sporadic melanoma. This evidence concerns the gene XPC and melanoma.